Holen Sie sich die Stockscreener-App
161.91
3.95%
-6.66
Handel nachbörslich:
161.91
Schlusskurs vom Vortag:
$168.57
Offen:
$166.93
24-Stunden-Volumen:
291.39K
Relative Volume:
1.05
Marktkapitalisierung:
$4.88B
Einnahmen:
$290.51M
Nettoeinkommen (Verlust:
$89.16M
KGV:
54.15
EPS:
2.99
Netto-Cashflow:
$119.18M
1W Leistung:
-4.14%
1M Leistung:
-13.49%
6M Leistung:
-9.54%
1J Leistung:
+2.13%
1-Tages-Spanne:
$161.03
$170.50
1-Wochen-Bereich:
$161.03
$171.00
52-Wochen-Spanne:
$141.72
$219.34
Krystal Biotech Inc Stock (KRYS) Company Profile
Firmenname
Krystal Biotech Inc
Sektor
Branche
Telefon
(412) 586-5830
Adresse
2100 WHARTON STREET, PITTSBURGH, PA
Vergleichen Sie KRYS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
161.91 | 4.88B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-20 | Eingeleitet | Goldman | Buy |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-12 | Eingeleitet | Citigroup | Buy |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-18 | Eingeleitet | Stifel | Buy |
| 2023-02-28 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-25 | Herabstufung | Goldman | Buy → Neutral |
| 2022-01-18 | Eingeleitet | BofA Securities | Buy |
| 2021-07-20 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-06-04 | Eingeleitet | Evercore ISI | Outperform |
| 2019-09-24 | Eingeleitet | Goldman | Neutral |
| 2019-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-24 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-06-24 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-30 | Eingeleitet | Guggenheim | Buy |
| 2018-09-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
Top Growth Companies With High Insider Ownership In April 2025 - simplywall.st
Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025 - The Manila Times
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Bought by Alliancebernstein L.P. - Defense World
Wellington Management Group LLP Sells 976 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Average Recommendation of “Buy” from Analysts - Defense World
Gene Therapy Market Top Players-Krystal Biotech, Inc., - openPR.com
JPMorgan Chase & Co. Buys 23,934 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech Becomes Oversold (KRYS) - Nasdaq
Krystal Biotech subsidiary Jeune Aesthetics taps Botox veteran as new CEO - The Business Journals
Is Kiniksa Pharmaceuticals (KNSA) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Krystal gets positive EU regulatory opinion for Vyjuvek - MSN
Jeune Aesthetics names Marc Forth as new CEO By Investing.com - Investing.com South Africa
Jeune Aesthetics names Marc Forth as new CEO - Investing.com Australia
Jeune Aesthetics Appoints Marc Forth As Chief Executive Officer - MarketScreener
Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer - GlobeNewswire
Aesthetic Medicine Powerhouse: BOTOX Veteran Takes Helm at Jeune Aesthetics - Stock Titan
5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025 - Zacks Investment Research
Krystal Biotech Q1 EPS Forecast Reduced by William Blair - Defense World
Krystal Biotech: Some Uncertainty, Some Value (NASDAQ:KRYS) - Seeking Alpha
Norges Bank Purchases New Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
William Blair Raises Earnings Estimates for Krystal Biotech - Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Sei Investments Co. - Defense World
Commonwealth Equity Services LLC Boosts Stake in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Commonwealth Equity Services LLC Purchases 190 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - The AM Reporter
(KRYS) Proactive Strategies - news.stocktradersdaily.com
Teacher Retirement System of Texas Purchases 1,369 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Bought by Teacher Retirement System of Texas - Defense World
US High Growth Tech Stocks With Promising Potential - Yahoo Finance
Krystal Biotech: Preparing To Chase Following Positive CHMP Opinion For VYJUVEK - Seeking Alpha
How To Trade (KRYS) - news.stocktradersdaily.com
3 High Growth Companies Insiders Are Betting On - simplywall.st
Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue? - Yahoo
Analysts Set Krystal Biotech, Inc. (NASDAQ:KRYS) PT at $220.00 - Defense World
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Raymond James Financial Inc. Takes $15.99 Million Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Is Krystal Biotech, Inc.'s (NASDAQ:KRYS) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Simply Wall St
Here's Why Krystal Biotech, Inc. (KRYS) is a Strong Momentum Stock - Yahoo Finance
US Bancorp DE Grows Stake in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Position Increased by Charles Schwab Investment Management Inc. - Defense World
Krystal Biotech president Suma Krishnan sells $8.9 million in shares - Investing.com India
Krystal Biotech president Suma Krishnan sells $8.9 million in shares By Investing.com - Investing.com South Africa
Krystal Biotech CEO Krishnan sells $8.89 million in stock By Investing.com - Investing.com Australia
Krystal Biotech CEO Krishnan sells $8.89 million in stock - Investing.com
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Keybank National Association OH - Defense World
How to Take Advantage of moves in (KRYS) - news.stocktradersdaily.com
Bank of New York Mellon Corp Has $26.53 Million Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait? - Nasdaq
Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
4.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):